ACADEMICIA: An International Multidisciplinary Research Journal
  • Year: 2021
  • Volume: 11
  • Issue: 4

Regional pretracheal lymphatic therapy of pulmonary complications COVID-19

  • Author:
  • Saidkhodjaeva Djurakhon*, Djumabaev Ekin**, Madazimov Madamin***, Madazimov Komil****
  • Total Page Count: 6
  • Page Number: 1344 to 1349

*Ph.D., Docent, Department of Faculty and Hospital Surgery, Andijan State Medical Institute, Uzbekistan

**Professor, Head of Department of Faculty and Hospital Surgery, Andijan State Medical Institute, Uzbekistan

***Professor, Department of Faculty and Hospital Surgery, Andijan State Medical Institute, Uzbekistan

****Ph.D., Assistant, Department of Faculty and Hospital Surgery, Andijan State Medical Intitute, Uzbekistan

Online published on 1 June, 2021.

Abstract

According to the latest data of radiation diagnosis and sectional studies, it became known that the most common clinical manifestation of a new version of COVID-19 coronavirus infection is pneumonitis or intersticiopathy. The scheme of pathomorphological changes in the lungs seems to be as follows: interstitial inflammation → Interstitial fibrosis (NSIP) • Fibrin → Organization → Interstitial fibrosis (OIP) • Metaplasia of the alveolar epithelium (Figi1,2), [2, 4,4].

Keywords

Pretracheal Lymphatic Therapy, Covid-19, Pulmonary Complications